Display Settings:

Format

Send to:

Choose Destination
    Curr Opin Chem Biol. 2008 Feb;12(1):11-7. Epub 2008 Mar 7.

    The Sirtuin family: therapeutic targets to treat diseases of aging.

    Source

    Sirtris Pharmaceuticals, Inc., 790 Memorial Drive, Cambridge, MA 02139, USA. jmilne@sirtrispharma.com

    Abstract

    Sirtuins have emerged as therapeutic targets to treat age-related diseases. There are seven human Sirtuins (SIRT1-7) that display diversity in cellular localization and function. Growing evidence suggests that small-molecule activators of SIRT1 may counteract age-related afflictions such as type 2 diabetes. Alternatively, inhibitors of SIRT2 may be useful in the treatment of neurodegenerative diseases such as Parkinson's disease. Recent discoveries of small-molecule and protein modulators of Sirtuin deacetylation activity have provided enormous insight into the biological and molecular functions of Sirtuins and have validated their potential as therapeutics.

    PMID:
    18282481
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk